Associations between ERα, ERβ, and AR genotypes and colon and rectal cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 12, 2005, Pages 2936-2942

  Slattery, Martha L ^a,d   Sweeney, Carol ^a   Murtaugh, Maureen ^a   Ma, Khe Ni ^a   Wolff, Roger K ^a   Potter, John D ^b   Caan, Bette J ^c   Samowitz, Wade ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; AR GENE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; CONFIDENCE INTERVAL; ERALPHA GENE; ERBETA GENE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR GENE; RECTUM CANCER; RISK REDUCTION; COLON TUMOR; GENETIC VARIABILITY; GENETICS; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RECTUM TUMOR; STATISTICAL MODEL; UNITED STATES;

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ADULT; AGED; ALLELES; COLONIC NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ANDROGEN; RECTAL NEOPLASMS; UNITED STATES; VARIATION (GENETICS);

EID: 30344482262     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0514     Document Type: Article

References (44)

1. Nanda K, Bastian LA, Hasselblad V, Simel DL. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 1999;93:880-8.
2. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002;288: 872-81.
3. Kampman E, Potter JD, Slattery ML, Caan BJ, Edwards S. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 1997; 8:146-58.
4. Slattery ML, Potter JD, Curtin K, et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001;61:126-30.
5. Slattery ML, Ballard-Barbash R, Potter JD, et al. Sex-specific differences in colon cancer associated with p53 mutations. Nutr Cancer 2004;49:41-8.
6. Slattery ML, Ballard-Barbash R, Edwards S, Caan BJ, Potter JD. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 2003;14:75-84.
7. Raigoso P, Sanz L, Vizoso F, et al. Estrogen and progesterone receptors in colorectal cancer and surrounding mucosa. Int J Biol Markers 2001;16:262-7.
8. Speer G, Cseh K, Winkler G, et al. Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers. Eur J Cancer 2001;37:1463-8.
9. Javid SH, Moran AE, Carothers AM, Redston M, Bertagnolli MM. Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer. Carcinogenesis 2005;26: 587-95.
10. Berta L, Fronticelli Baldelli C, Fazzari A, et al. Sex steroid receptors, secondary bile acids and colorectal cancer. A possible mechanism of interaction. Panminerva Med 2003;45:261-6.
11. Witte D, Chirala M, Younes A, Li Y, Younes M. Estrogen receptor β is expressed in human colorectal adenocarcinoma. Hum Pathol 2001;32:940-4.
12. Waliszewski P, Blaszczyk M, Wolinska-Witort E, Drews M, Snochowski M, Hurst RE. Molecular study of sex steroid receptor gene expression in human colon and in colorectal carcinomas. J Surg Oncol 1997;64:3-11.
13. Katzenellenbogen BS, Montano MM, Ediger TR, et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 2000;55:163-93; discussion 194-5.
14. Katzenellenbogen BS, Choi I, Delage-Mourroux R, et al. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 2000;74:279-85.
15. Fiorelli G, Picariello L, Martineti V, Tonelli F, Brandi ML. Functional estrogen receptor β in colon cancer cells. Biochem Biophys Res Commun 1999;261:521-7.
16. Qiu Y, Waters CE, Lewis AE, Langman MJ, Eggo MC. Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor β. J Endocrinol 2002; 174:369-77.
17. Gennari L, Merlotti D, De Paola V, et al. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am J Epidemiol 2005;161:307-20.
18. Westberg L, Baghaei F, Rosmond R, et al. Polymorphisms of the androgen receptor gene and the estrogen receptor β gene are associated with androgen levels in women. J Clin Endocrinol Metab 2001;86:2562-8.
19. Sundarrajan C, Liao WX, Roy AC, Ng SC. Association between estrogen receptor-β gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 2001;86:135-9.
20. Rosenkranz K, Hinney A, Ziegler A, et al. Systematic mutation screening of the estrogen receptor β gene in probands of different weight extremes: identification of several genetic variants. J Clin Endocrinol Metab 1998;83: 4524-7.
21. Ding D, Xu L, Menon M, Reddy GP, Barrack ER. Effect of a short CAG (glutamine) repeat on human androgen receptor function. Prostate 2004;58: 23-32.
22. Krithivas K, Yurgalevitch SM, Mohr BA, et al. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol 1999;162:137-42.
23. Hoque A, Albanes D, Lippman SM, et al. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control 2001;12:627-33.
24. Slattery ML, Potter J, Caan B, et al. Energy balance and colon cancer-beyond physical activity. Cancer Res 1997;57:75-80.
25. Edwards S, Slattery ML, Mori M, et al. Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 1994;140:1020-8.
26. Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, Kerber R. A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 1994;94:761-6.
27. van Meurs JB, Schuit SC, Weel AE, et al. Association of 5′ estrogen receptor α gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet 2003;12:1745-54.
28. Slattery ML, Edwards SL, Palmer L, et al. Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. Mutat Res 2000;432:7-14.
29. Slattery ML, Curtin K, Ma K, et al. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev 2002;11:541-8.
30. Slattery ML, Anderson K, Curtin K, et al. Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 2001;483:73-81.
31. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000;92:1831-6.
32. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
33. Singh S, Langman MJ. Oestrogen and colonic epithelial cell growth. Gut 1995;37:737-9.
34. Liao S. Androgen action: molecular mechanism and medical application. J Formos Med Assoc 1994;93:741-51.
35. Montano MM, Deng H, Liu M, Sun X, Singal R. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 2004;23:2442-53.
36. Tutton PJ, Barkla DH. Steroid hormones as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells [review]. Anticancer Res 1988;8:451-6.
37. Konstantinopoulos PA, Kominea A, Vandoros G, et al. Oestrogen receptor β (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003;39:1251-8.
38. 12Val] K-Ras-mediated NIH3T3 cell transformation. Oncology 1998;55 Suppl 1:45-52.
39. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol Cell Biol 1995;15:4971-9.
40. Dieudonne MN, Leneveu MC, Giudicelli Y, Pecquery R. Evidence for functional estrogen receptors α and β in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol 2004; 286:C655-61.
41. Izbicki JR, Schmitz R, Kamran D, Izbicki W. Androgens as promoters of colon carcinogenesis. Cancer Detect Prev 1983;6:355-62.
42. Ferro P, Catalano MG, Raineri M, et al. Somatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instability. Cancer Genet Cytogenet 2000;123:35-40.
43. Mulholland DJ, Cheng H, Reid K, Rennie PS, Nelson CC. The androgen receptor can promote β-catenin nuclear translocation independently of adenomatous polyposis coli. J Biol Chem 2002;277:17933-43.
44. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.